• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 2 filed

    12/30/20 4:17:36 PM ET
    $AMRH
    Semiconductors
    Technology
    Get the next $AMRH alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-38286
    Issuer: AMERI Holdings, Inc.
    Exchange: The Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 100 Canal Pointe Blvd
    Suite 108
    Princeton NEW JERSEY 08540
    Telephone number: 925-984-4191
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Warrant
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, The Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2020-12-30 By O'Neil Blake Senior Specialist
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AMRH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMRH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AMRH
    SEC Filings

    View All

    SEC Form 8-K filed

    8-K - Enveric Biosciences, Inc. (0000890821) (Filer)

    1/15/21 4:16:05 PM ET
    $AMRH
    Semiconductors
    Technology

    SEC Form 424B5 filed

    424B5 - Enveric Biosciences, Inc. (0000890821) (Filer)

    1/13/21 5:28:07 PM ET
    $AMRH
    Semiconductors
    Technology

    SEC Form 8-K/A filed

    8-K/A - Enveric Biosciences, Inc. (0000890821) (Filer)

    1/13/21 5:25:09 PM ET
    $AMRH
    Semiconductors
    Technology

    $AMRH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ameri Holdings Completes Spin-Off and Tender Offer, Changes Name to Enveric Biosciences and Begins Trading on the Nasdaq Under the Symbol "ENVB"

    NAPLES, Fla., Dec. 31, 2020 /PRNewswire/ -- Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), formerly AMERI Holdings, Inc. (NASDAQ: AMRH), a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments with novel cannabinoid medicines, announced the completion of the previously announced spin-off of the IT services business of the Company and the tender offer, whereby the Company purchased all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Company common stock, or if applicable, shares of Company preferred stock., and Jay Pharma became

    12/31/20 8:21:00 AM ET
    $AMRH
    Semiconductors
    Technology

    AMERI Holdings Announces 1-for-4 Reverse Stock Split

    ATLANTA, Dec. 30, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri", the "Company"), announced a 1-for-4 reverse split of its common stock, effective as of 4:02 pm Eastern Time, December 30, 2020 (the "Reverse Stock Split"). As previously announced, at the special meeting of stockholders held on December 29, 2020, Ameri's stockholders approved all proposals to complete the proposed tender offer (the "Offer"), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement a

    12/30/20 12:59:00 PM ET
    $AMRH
    Semiconductors
    Technology

    AMERI Holdings' Stockholders Approve All Proposals To Complete Tender Offer For Jay Pharma Shares

    ATLANTA, Dec. 29, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri", the "Company"), announced the voting results of the Special Meeting of stockholders that was held today. Based on the report from the Inspector of Elections, Ameri obtained sufficient votes for each proposal required to complete the previously announced proposed tender offer (the "Offer"), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement and Termination of Amalgamation Agreement dated August

    12/29/20 10:10:00 AM ET
    $AMRH
    Semiconductors
    Technology

    $AMRH
    Leadership Updates

    Live Leadership Updates

    View All

    AMERI Holdings' Stockholders Approve All Proposals To Complete Tender Offer For Jay Pharma Shares

    ATLANTA, Dec. 29, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri", the "Company"), announced the voting results of the Special Meeting of stockholders that was held today. Based on the report from the Inspector of Elections, Ameri obtained sufficient votes for each proposal required to complete the previously announced proposed tender offer (the "Offer"), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement and Termination of Amalgamation Agreement dated August

    12/29/20 10:10:00 AM ET
    $AMRH
    Semiconductors
    Technology